Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease.
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.Gut adaptation and the glucagon-like peptidesThe role of gut hormones in glucose homeostasisEmerging treatment options for short bowel syndrome: potential role of teduglutideGlucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway.Endomicroscopic and Transcriptomic Analysis of Impaired Barrier Function and Malabsorption in Environmental EnteropathyA pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patientsEnteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs.Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation.Dietary lipids and sweeteners regulate glucagon-like peptide-2 secretion.Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon.Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer.Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats.Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.Role of Incretin Axis in Inflammatory Bowel Disease.Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets.Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
P2860
Q26752511-E1A5FF9C-8DDB-4B0B-B9CF-CD932BF770B5Q34175049-59EB5624-39F1-43DB-B7D3-87DDDDA5CCAAQ34526042-6700F1ED-90E4-4B3F-A5DD-7FF391722065Q35251016-8FC96263-6B7D-4E0D-9E07-A0C55484EA7DQ35304614-5BE755CC-F274-4466-BC5C-41E51EBB9F91Q35756432-6709E6AC-8B0D-4B9D-AAE8-AA2AD9B45282Q35981027-D878EED3-CF2C-4EFD-B7EA-DFE8E4162B78Q37247764-13CA0F4B-4D80-4895-9BF8-220BB2D4D37CQ37662980-EC012752-F76C-40DA-9853-BC1D7D7F0587Q37685841-72C876A4-B6C1-4073-9960-53DAA10662A5Q38751579-952B38CF-F3B4-43FA-B9F5-4EB7CD5FD07FQ38870486-EC55B9C3-8C8C-42F4-8521-BFF077E24467Q39201298-2A37A3A1-8DEF-4004-B387-AEE84752C9F7Q42500339-E6EF25DC-8052-4076-B03E-0E817C8E3671Q42721362-9CA24CF2-FBC9-44AC-A96C-CE76E1F90587Q42943394-BCD74F81-2139-475C-A0B1-8B09640500D5Q43168687-05B3971F-306E-48E2-95B4-EA1C2D9C7E75Q47103249-CD21EA17-8025-4CE2-9567-AFBD323C28B0Q48767793-433808F8-705E-488E-9AC6-6F75897E56D7Q55280611-79083837-E720-4E54-9C40-56C97CB6D208
P2860
Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Circulating levels of glucagon ...... th inflammatory bowel disease.
@en
type
label
Circulating levels of glucagon ...... th inflammatory bowel disease.
@en
prefLabel
Circulating levels of glucagon ...... th inflammatory bowel disease.
@en
P2093
P2860
P1476
Circulating levels of glucagon ...... th inflammatory bowel disease.
@en
P2093
P2860
P304
P356
10.1152/AJPREGU.2000.278.4.R1057
P577
2000-04-01T00:00:00Z